Order Article Reprints

Suárez-Herrera N, Li CHZ, Leijsten N, Karjosukarso DW, Corradi Z, Bukkems F, Duijkers L, Cremers FPM, Hoyng CB, Garanto A, et al. Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells. 2024; 13(7):601. https://doi.org/10.3390/cells13070601

Suárez-Herrera, Nuria, Catherina H. Z. Li, Nico Leijsten, Dyah W. Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P. M. Cremers, Carel B. Hoyng, Alejandro Garanto, and et al. 2024. "Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease" Cells 13, no. 7: 601. https://doi.org/10.3390/cells13070601

Suárez-Herrera, N., Li, C. H. Z., Leijsten, N., Karjosukarso, D. W., Corradi, Z., Bukkems, F., Duijkers, L., Cremers, F. P. M., Hoyng, C. B., Garanto, A., & Collin, R. W. J. (2024). Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells, 13(7), 601. https://doi.org/10.3390/cells13070601